Travere Therapeutics (TVTX) 424B5 Prospectus supplement for primary offering

S-3 424B5 EX-FILING FEES 333-281194 0001438533 Travere Therapeutics, Inc. The prospectus is not a final prospectus for the related offering. 0001438533 2024-10-30 2024-10-30 0001438533 1 2024-10-30 2024-10-30 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

Travere Therapeutics, Inc.

Table 1: Newly Registered and Carry Forward Securities

		Security Type	Security Class Title	Fee Calculation or Carry Forward Rule	Amount Registered	Proposed Maximum Offering Price Per Unit	Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee	Carry Forward Form Type	Carry Forward File Number	Carry Forward Initial Effective Date	Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward
Newly Registered Securities
Fees to be Paid	1	Equity	Common Stock, par value $0.0001 per share	457(r)			$ 100,000,000.00	0.0001531	$ 15,310.00
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities
			Total Offering Amounts:				$ 100,000,000.00		$ 15,310.00
			Total Fees Previously Paid:						$ 0.00
			Total Fee Offsets:						$ 0.00
			Net Fee Due:						$ 15,310.00

Offering Note

¹ The Proposed Maximum Aggregate Offering Price is being used to calculate the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. The Amount of Registration Fee is calculated in accordance with Rule 456(b) and Rule 457(r) of the Securities Act of 1933, as amended. This "Calculation of Registration Fee" table shall be deemed to update the "Calculation of Registration Fee" table in the registrant's registration statement on Form S-3ASR filed with the Securities and Exchange Commission on August 1, 2024 (File No. 333-281194).